BSX vs CTSO · P/E 20, rev $16.75B vs $28.8M cap
Boston Scientific Corp (BSX) versus Cytosorbents Crp (CTSO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
CTSO does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CTSO currently screens at market cap $28.8M.
Not investment advice. Open the BSX and CTSO stock pages for the full models.
Not investment advice.